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SUMMARY
Staphylococcus aureus is a part of our normal microbial flora but also a serious pathogen causing
a wide range of infectious diseases. In particular, methicillin resistant S. aureus (MRSA) strains
are an increasing problem in hospitals all over the world because of their resistance to the
antibiotics commonly used to treat S. aureus infections. In this thesis work a novel surface
protein of MRSA, Pls, was characterized and its effects on bacterial adhesion, invasion to host
cells and pathogenesis of septic arthritis were examined. In addition, evolutionary aspects were
considered.
Pls (Plasmin sensitive) protein was found in a group of MRSA strains that failed to agglutinate
in rapid clinical tests designed for identification of S. aureus strains by detecting binding of
immunoglobulin G (IgG) and fibrinogen (Fgen) onto S. aureus cell surface. Pls was found to
associate with carbohydrate, and the protein was purified from the clinical MRSA isolate 1061
using affinity chromatography on immobilized wheat germ agglutinin (WGA). The protein was
surface-located and its apparent mass in this strain was 230 kDa. Pls occurred in three
immunoreactive molecular forms in the cell wall of S. aureus. These variants were 230, 175 and
68 kDa in apparent mass, and the amounts of the latter two increased after exogenous addition
of trypsin or plasmin, hence the name Pls.
The pls gene was cloned and sequenced. The predicted amino acid sequence revealed a C-
terminal LPDTG cell wall attachment site and three different repeat regions, one of which, a 282
amino acid serine-aspartate (SD) dipeptide repeat, is typical to a family of staphylococcal SD
repeat surface proteins. In addition to the repeats, the Pls sequence contained a non-repeat,
unique region. The apparent molecular size of Pls varied between clinical isolates of MRSA. This
inter-strain size variation in Pls was found to depend on length variation in the three repeat
regions. The genomic location of the pls gene was found to be associated to that of the mecA
gene encoding methicillin resistance.
A mutant of MRSA strain 1061 deficient in Pls was constructed by allelic replacement, and the
mutation was complemented with a plasmid encoding Pls. Pls expression reduced the adherence
of MRSA bacteria to immobilized host extracellular matrix and plasma proteins fibronectin (Fn),
Fgen, IgG and laminin. However, binding of the same proteins in soluble form, especially of IgG,
was not reduced by Pls expression. A difference in adhesiveness similar to that between the wild
type and the mutant strains, was seen between Pls positive and Pls negative clinical MRSA
isolates. The reduced adherence caused by Pls expression was hypothesized to result from steric
hindrance of interactions between staphylococcal surface adhesins and their immobilized targets.
Pls expression also reduced the internalization of MRSA bacteria by a human kidney cell line.
In spite of its reduced in vitro adherence and invasion, the Pls positive MRSA strain 1061 caused
a more severe septic arthritis and sepsis and gave rise to a higher mortality rate after an
intravenous infection in a mouse model of septic arthritis, as compared to its Pls deficient
derivative.
The pls gene was found more frequently in clinical human isolates of Staphylococcus sciuri than
in MRSA strains. S. sciuri is a species common in normal skin microbial flora of lower mammals
like rodents, but sometimes isolated from humans as well. Pls was expressed in S. sciuri,
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although at a lower level than in S. aureus, and it contained bound carbohydrate as it could be
purified using WGA affinity chromatography. The high frequency of pls in these S. sciuri strains
is interesting since methicillin resistance encoding mecA gene may have originated from this
species and it could be that also pls, which in MRSA genome is associated to the mecA gene, has
its origins in S. sciuri or its evolutionary relatives.
  
x
11. INTRODUCTION
1.1. Clinical background
Staphylococcus aureus is a part of our normal microbial flora. The primary reservoir in the body
is thought to be in the anterior nares, from where the bacterium spreads to multiple sites of the
skin and mucosal surfaces. According to different studies 10-35 % of people are persistent
carriers of S. aureus, 20-75 % are transient carriers, and 5-50 % are non-carriers (reviewed in
Nouwen et al., 2001). Carriage is a risk factor for infections in various clinical settings. In a
recent study, hospital-acquired bacteremia was three times more frequent in S. aureus carriers
than in non-carriers. Interestingly, however, bacteremia-related death was found to be higher in
non-carriers than in carriers (Wertheim et al., 2004). A damage of the skin surface or a mucosal
barrier opens an access for the bacteria to tissues and bloodstream. S. aureus is able to cause a
wide variety of diseases ranging from local abscesses to bacteremia and severe invasive
infections in various organs, or toxin-mediated diseases (reviewed by Lowy, 1998). The
bacterium has a versatile arsenal of secreted and surface molecules which contribute to its ability
to cause disease.
Treatment of S. aureus infections has been complicated by the emergence of antibiotic resistant
strains. Today, practically all S. aureus isolates produce -lactamase and are resistant to -lactam
antibiotics. The use of penicillins capable of resisting -lactamase action, also called
staphylococcal penicillins, has been the treatment of choice in S. aureus infections ever since the
first antibiotic in this group, methicillin, was introduced in 1960. However, the first methicillin
resistant strain was isolated already in 1961 (Jevons, 1961) and the prevalence of methicillin
resistant S. aureus (MRSA) continues to increase. In 1998-2002, 51 % of S. aureus strains
isolated from intensive care patients were MRSA in the USA (de Sousa and de Lencastre, 2004).
In 1999-2002, 20 % of the European S. aureus blood isolates were MRSA. For example the
antibiotic usage and clinical practices characteristic of each country caused a large variation in
MRSA prevalence between countries and hospitals in Europe. The prevalence was 1 % or less
in Scandinavia and the Netherlands whereas more than 40% of the strains were MRSA in
Southern Europe as well as in the UK and Ireland (Tiemersma et al., 2004). In addition to
hospital-acquired MRSA (H-MRSA), the amount of community-acquired MRSA (C-MRSA) has
increased in recent years. Unlike the H-MRSA, the C-MRSA strains isolated from patients
without a hospital connection are usually susceptible to several antibiotics (Chambers, 2001).
Hospital infections are often caused by multidrug-resistant MRSA strains and the only two
antibiotics that remain effective are the glycopeptide vancomycin and the new antibiotic
linezolid, which belongs to the class of oxazolidinones. Linezolid disrupts bacterial growth by
inhibiting the formation of an initiation complex in protein synthesis and allows oral therapy,
whereas vancomycin has to be used intravenously. Vancomycin binds to peptidoglycan
precursors and thus blocks the cell wall synthesis. The high frequency of vancomycin resistant
Enterococcus faecalis strains has raised the fear of the spread of vancomycin resistance
determinants; in particular by the transfer of the plasmid-encoded vanA to MRSA. The first
clinical MRSA strain with reduced susceptibility to vancomycin (minimum inhibitory
concentration (MIC) = 8µg/ml) was isolated in Japan in 1996 (Hiramatsu et al., 1997). This
vancomycin intermediate S. aureus (VISA) strain did not have a van gene. The first clinical
vancomycin resistant S. aureus (VRSA) strain (MIC32µg/ml), containing the enterococcal vanA
2gene (CDC, 2002), was reported in the United States in 2002.  
1.2. Interactions of S. aureus with host molecules
Staphylococcus aureus has a wide range of potential virulence factors, either surface associated
or secreted. Bacterial adhesion to host tissues is an important initiating step in many types of
infections. It helps the bacteria to resist mechanical defence in the body, enables colonization and
growth, and may be the first phase in bacterial invasion into mammalian cells. Adhesins of S.
aureus with a known cellular or circulating ligand are presented in Table 1. Some of them will
be discussed below in greater detail. Additionally, S. aureus produces a wide array of
extracellular enzymes such as hyaluronate lyase, thermostable nuclease and different proteases
and lipases. Some of them are important for nutritional purposes but have also been suggested
to be involved in pathogenesis (reviewed in Arvidson, 2000). Exotoxins are involved in many
diseases caused by S. aureus (reviewed by Bohach and Foster, 2000). Alpha-, beta-, delta- and
gamma-toxins as well as Panton-Valentine leukocidin are membrane-active toxins which cause
cell lysis and have in most cases only a contributory role in pathogenesis. On the other hand,
pyrogenic toxins, like the enterotoxins causing food poisonings and the toxic shock syndrome
toxin, originally linked to the use of highly absorbent tampons during menstruation, as well as
exfoliative toxins causing staphylococcal scalded skin syndrome, can cause a serious systemic
disease. These toxins are able to modulate the immune defence by acting as superantigens
through binding to T cell receptors and major histocompatibility complex class II molecules on
the surface of antigen presenting cells. This binding leads to a massive T cell activation, cytokine
production, systemic symptoms and shock.
1.2.1. S. aureus surface proteins
1.2.1.1. LPXTG proteins
Many surface proteins of Gram-positive bacteria have a conserved C-terminal sorting signal,
which consists of an LPXTG sequence followed by a hydrophobic domain and a tail containing
mostly positively charged amino acids (Fischetti et al., 1990). Translocation through the
cytoplasmic membrane, which is enabled by an N-terminal signal peptide, is followed by
recognition of the sorting signal by the sortase enzyme (Mazmanian et al., 1999) and subsequent
cleavage between threonine (T) and glycine (G) of the LPXTG motif. The carboxyl of threonine
is then amide-linked to the free amino group of the peptidoglycan crossbridge, which in S. aureus
is pentaglycine (Navarre and Schneewind, 1994; Schneewind et al., 1995). In a data search of six
complete or partial S. aureus genomic sequences, twenty-one potential open reading frames
containing the LPXTG motif were found (Roche et al., 2003a). Ten of these were previously
uncharacterized and named as Staphylococcus aureus surface (Sas) proteins SasA-SasK. Since
then, SasE and SasJ have been renamed as IsdA and IsdB. The genes coding for them are a part
of the isd (iron-responsive surface determinant) locus and are preceded by a ferric uptake
repressor (Fur) box (Mazmanian et al., 2002). The previously characterized LPXTG proteins
were the protein A (SpA), the clumping factors ClfA and ClfB, the collagen-binding protein Cna,
the fibronectin-binding proteins FnBPA and FnBPB (Table 1, domain structures in Figure 1), the
serine-aspartate repeat proteins SdrC, D and E, FmtB and Pls, the topic of this thesis (Figure 1).
Many of these surface protein adhesins are able to adhere to extracellular matrix (ECM)
components of the host and have also been called MSCRAMMs (microbial surface components
recognizing adhesive matrix molecules; reviewed in Foster and Höök, 1998).
3Figure 1. Domain structures of the characterized S. aureus LPXTG proteins A) not containing an SD (serine-
aspartate) repeat and B) containing an SD repeat. A and C, unique regions; B, repeated sequences homologous
inside an individual protein but not necessarily between proteins (the homologous repeats are marked with an
identical colour); D and Du, repeated sequences in the FnBP proteins; R, SD repeat; W, wall-spanning region; M,
membrane-spanning region. The LPXTG sequence is marked with a black arrowhead and a vertical line. The black
box denotes a signal sequence. The domains involved in binding to host molecules are marked (*). SpA, protein A;
Cna, collagen adhesin; FnBPA and FnBPB, fibronectin-binding proteins A and B; FmtB, factor that affects the
methicillin resistance levels in the presence and absence of Triton X-100; Bap, biofilm-associated protein; SasG,
Staphylococcus aureus surface protein G; Pls, plasmin sensitive protein; ClfA and ClfB, clumping factors A and
B; SdrC, SdrD and SdrE, SD repeat proteins C, D and E; Bbp, bone sialoprotein-binding protein. For references
see Table 1 and the text.
4Table 1.  S. aureus adhesins with a shown or putative effect on virulence, and examples of in vivo models used to
study their role in virulence. +, increased virulence; -, no effect; a reduced virulence is specifically mentioned. Only
the molecules with a recognized host ligand are included. Additionally, S. aureus bacteria are able to bind at least
laminin (Lopes et al., 1985), but a molecule responsible for specific binding has not been identified.
S. aureus
molecule Ligand References In vivo model used Virulence References
LPXTG surface adhesins
SpA Fc part of IgG Forsgren and Sjöquist,
1966; Löfdahl et al.,
1983; Sjödahl, 1977;
Uhlén et al., 1984
mouse septic arthritis
and septic death
 + Palmqvist et al., 2002
mouse skin lesion  + Patel et al., 1987
Fab of IgG Inganäs et al., 1980;
Roben et al., 1995
mouse intraperitoneal
infection
 + Patel et al., 1987
complement receptor
gC1qR/p33, e.g. on
activated platelets
Nguyen et al., 2000
von Willebrand factor Hartleib et al., 2000
Cna collagen Patti et al., 1992;
Patti et al., 1993;
Switalski et al., 1989
mouse septic arthritis  + Patti et al., 1994
mouse septic death immunization
protective
Nilsson et al., 1998
rabbit keratitis  + Rhem et al., 2000
rat endocarditis  + Hienz et al., 1996
mouse osteomyelitis  + Elasri et al., 2002
mouse septic arthritis  - Elasri et al., 2002
FnBPA /
FnBPB
fibronectin Flock et al., 1987;
Greene et al., 1995;
Jönsson et al., 1991;
Jönsson, 1992;
Kuusela, 1978; Massey
et al., 2001; Signäs et
al., 1989
rat endocarditis  + Kuypers and Proctor, 1989;
Que et al., 2001
rat endocarditis  - Flock et al., 1996
rat endocarditis immunization
protective
Schennings et al., 1993
elastin Roche et al., 2004 rat pneumonia reduced
virulence
McElroy et al., 2002
fibrinogen Wann et al., 2000 mouse mastitis  + Brouillette et al., 2003b
Hsp60 Dziewanowska et al.,
2000
Bap attachment to inert
surfaces, 
cell-cell adhesion
Cucarella et al., 2001 ovine mastitis early adherence
reduced,
persistence
increased
Cucarella et al., 2002;
Cucarella et al., 2004
LPXTG surface adhesins with an SD repeat
ClfA fibrinogen McDevitt et al., 1994 mouse septic arthritis  + Josefsson et al., 2001
platelet membrane
118kDa protein
Siboo et al., 2001 rat endocarditis  + Moreillon et al., 1995; Que
et al., 2001; Stutzmann
Meier et al., 2001
ClfB fibrinogen Ní Eidhin et al., 1998 rat endocarditis  +/- Entenza et al., 2000
type I cytokeratin 10 O´Brien et al., 2002b
Bbp bone sialoprotein Tung et al., 2000;
Yacoub et al., 1994
5S. aureus
molecule Ligand References In vivo model used Virulence References
Other surface associated adhesive molecules
EbpS elastin Downer et al., 2002;
Park et al., 1991; Park
et al., 1996
Emp fibronectin,
fibrinogen, collagen,
vitronectin
Hussain et al., 2001
Ebh (1,1
MDa)
fibronectin Clarke et al., 2002 mouse skin abscess  - Clarke et al., 2002
VnBP vitronectin Liang et al., 1995
heparan sulfate Liang et al., 1992
PIA/
PNSG a 
cell-cell adhesion Cramton et al., 1999 mouse kidney abscess immunization
protective
McKenney et al., 1999
Secreted adhesive molecules
Efb (Fib) fibrinogen Bodén and Flock, 1994 rat wound infection  + Palma et al., 1996
complement C3 Lee et al., 2004 rat endocarditis  - Palma et al., 1996
coagulase prothrombin, 
fibrinogen
Bodén and Flock,
1989; Hemker et al.,
1975; Kawabata et al.,
1985; McDevitt et al.,
1992; Phonimdaeng  et
al., 1988
rat endocarditis  - Moreillon et al., 1995;
Stutzmann Meier et al.,
2001
mouse hematogenous
pneumonia
 + Sawai et al., 1997
Eap/Map fibronectin,
fibrinogen,
vitronectin,
thrombospondin,
bone sialoprotein,
collagen, osteopontin,
prothrombin, neutral
phosphatase and
some other molecules
on S. aureus surface,
ICAM-1, Eap 
Chavakis et al., 2002;
Flock and Flock, 2001;
Homonylo McGavin et
al., 1993; Jönsson et
al., 1995; Palma et al.,
1999; Hussain et al.,
2002; Kreikemeyer et
al., 2002; reviewed by
Harraghy et al., 2003
mouse wound
infection
 - Chavakis et al., 2002
mouse kidney abscess  -
mouse peritonitis
(inhibition of
neutrophil emigration)
 +
mouse acute septic
arthritis, osteomyelitis
and abscess
 - Lee et al., 2002
mouse chronic septic
arthritis, osteomyelitis
and abscess
 +
vWbp von Willebrand factor Bjerketorp et al., 2002
a) polysaccharide intercellular adhesin
The LPXTG surface proteins share additional features in their structural organization: repeat
sequences and in most cases a non-repeat, unique domain (Figures 1A and B). SpA has five 58
amino acid (aa) long IgG binding repeats (Sjödahl, 1977). The collagen binding region of Cna
has been localized to the non-repeat domain, whose crystal structure has been resolved
(Symersky et al., 1997). The FnBPs were first found to bind fibronectin via their C-terminal 38
aa long D repeats (Signäs et al., 1989) but later on, several fibronectin binding sites throughout
the domains B, C and D were identified in FnBPA (Massey et al., 2001). The A domain of
FnBPA has been found to additionally bind fibrinogen (Wann et al., 2000) and the A domains
of both FnBPA and B to bind elastin (Roche et al., 2004). The function of FmtB is not known
but Tn551 inactivation of the gene has been shown to reduce resistance of the cells to methicillin
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(biofilm-associated protein), has been described. The bap gene was not found in the six genomes
searched by Roche et al., and has so far been found only in S. aureus bovine mastitis isolates. Bap
promotes primary attachment to inert surfaces and intercellular adhesion (Cucarella et al., 2001).
1.2.1.2. SD repeat proteins
A common feature in a group of LPXTG proteins, the so called SD repeat proteins, is a region
containing repeats of the serine-aspartate (SD) dipeptide. This region is located in the C-terminal
end, preceding the wall and membrane spanning sequences (Figure 1B). Among molecules of this
family, the clumping factors ClfA and ClfB bind fibrinogen (Fgen) with their A regions
(McDevitt et al., 1995; Ní Eidhin et al., 1998) whereas the SD repeat is required for spanning the
peptidoglycan and displaying the A region in a functional way on the cell surface (shown for
ClfA, Hartford et al., 1997). The A region of ClfB additionally binds cytokeratin 10, which is
expressed on keratinocyte and nasal epithelial cell surfaces (O´Brien et al., 2002b). The A region
of ClfA has a Ca2+ binding motif. Binding of Ca2+ inhibits the binding of Fgen to ClfA (O´Connell
et al., 1998). Binding of Fgen by ClfB is inhibited by Ca2+ as well but it does not contain a motif
similar to ClfA (Ní Eidhin et al., 1998). The SdrC, D and E proteins have an additional repeat
region between the A region and the SD repeat. These B repeats are also able to bind Ca2+ and
have a motif similar to that of ClfA. Additionally, a conserved motif TYTFTDYVD of unknown
function is found in the A regions of the ClfA and B as well as the SdrC, D and E proteins
(Josefsson et al., 1998). SdrE is able to induce aggregation of platelets. The aggregation can be
inhibited with added recombinant A region of this protein. Plasma proteins are also needed for
this interaction suggesting that the binding is indirect (O´Brien et al., 2002a). So far no functions
for the SdrC and D are known. Yet another member of the SD repeat protein family is the bone
sialoprotein-binding protein Bbp which is an LPXTG protein but was not found in the six S.
aureus genomes searched by Roche et al. (2003a). Bbp interacts specifically with bone
sialoprotein (Yacoub et al., 1994) and has the conserved A region motif (Tung et al., 2000).
1.2.2. Host molecules interacting with S. aureus
1.2.2.1. Extracellular matrix
Eukaryotic cells produce extracellular matrix (ECM) around them. Apart from acting as a
relatively stable support ECM is in continuous interaction with the cells. It is formed by soluble
proteoglycan and glycoproteins and insoluble collagen and elastin fibres. The proportions of these
classes of molecules vary depending on the tissue (Ayad et al., 1998; Hay, 1991). A specialized,
sheet-like form of ECM, basement membrane, which is produced by e.g. epithelial and
endothelial cells, is composed of type IV collagen and laminin networks bridged by entactin and
heparan sulfate proteoglycan (Yurchenco and Schittny, 1990). Eukaryotic cells are primarily
bound to ECM by their transmembrane surface receptors, integrins. The integrins are formed by
various combinations of - and -subunits which specifically bind different ligands that
commonly contain an Arg-Gly-Asp (RGD) target sequence (Ruoslahti, 1991).
Collagens, the most abundant family of ECM proteins, often have a structural role. Their basic
structure is a helix formed by three chains with a repeating Gly-X-Y sequence where X is
frequently a proline and Y a hydroxyproline (Linsenmayer, 1991). Elastin, another fibre forming
protein, is insoluble and very hydrophobic. It is a major component of elastic fibres giving
resiliency e.g. in lungs, skin, ligaments and cartilage (Mecham and Heuser, 1991). The soluble
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covalently bound glycosaminoglycan (GAG) moiety. Based on repeated disaccharide structures
the GAGs are grouped as hyaluronic acid, chondroitin/dermatan sulfate, keratan sulfate or
heparan sulfate/heparin (Wight et al., 1991). Another group of ECM soluble proteins are various
glycoproteins, for example laminin and fibronectin. Laminin, a major component of the basement
membranes, belongs to laminin family of large cross-shaped glycoproteins which contain three
chains (Tryggvason, 1993). Fibronectin (Fn) is a large dimeric glycoprotein found both in the
ECM and as a soluble protein in plasma. Its binding to collagen, heparin, fibrin and cell surface
integrins has been well characterized (Yamada, 1991; Pierschbacher and Ruoslahti, 1984). Other
glycoproteins include for example vitronectin, which is found in plasma as well, thrombospondin,
which is abundant in platelets, tenascin, entactin and the bone sialoprotein.
1.2.2.2. Plasma proteins
Immunoglobulin G (IgG) is the major antibody in secondary immune responses. Another
important plasma protein fibrinogen (Fgen) is involved in blood clotting. Two small
fibrinopeptides are released from Fgen as a result of cleavage by thrombin leading to formation
of fibrin monomers that spontaneously aggregate to fibrin fibres forming a blood clot (Stryer,
1988). A platelet surface integrin IIb3 is also able to bind Fgen, which contributes to formation
of platelet thrombi (Ruggeri, 1993). Fibrin clots are lysed by plasmin, a serine protease formed
by proteolytic activation of the plasma proenzyme plasminogen (Plg). Plg is activated by the
mammalian plasminogen activators tPA (tissue-type Plg activator) or uPA (urokinase) in a tightly
controlled system where binding to a surface, like a fibrin clot, greatly enhances the activation.
Plg binds to its receptors using its five lysine-binding kringle structures at the N-terminus of the
molecule. The receptor-bound Plg/plasmin is well protected from inactivation by its main
physiological inhibitor 2-antiplasmin. Plasmin itself is able to bind and degrade many ECM
components, and it can induce even more ECM breakdown by activating procollagenases.
Degradation of ECM is needed for many physiological and pathological processes during cellular
migration (reviewed by Lähteenmäki et al., 2001).
1.2.2.3. Interactions of S. aureus with plasminogen
Like many pathogenic bacteria, S. aureus has been shown to bind Plg which is also activated to
proteolytic plasmin on the staphylococcal surface in the presence of tPA (Kuusela and Saksela,
1990). Inosine 5'-monophosphate dehydrogenase, -enolase and ribonucleotide reductase subunit
2 have been suggested as putative Plg-binding proteins in S. aureus (Mölkänen et al., 2002). In
many species the receptors are multifunctional proteins involved e.g. in metabolism, adhesion or
motility (Lähteenmäki et al., 2001). S. aureus strains which carry a prophage containing the sak
gene produce staphylokinase (SAK), a staphylococcal plasminogen activator. SAK forms a
stoichiometric complex with Plg or plasmin which acts as a plasminogen activator (Lijnen et al.,
1991) that enhances activation of Plg to S. aureus surface receptors (Mölkänen et al., 2002;
reviewed in Lähteenmäki et al., 2001). It has been shown that pathogenic bacteria like Salmonella
can utilize surface-bound plasmin for degradation of mammalian ECM components and for
penetration through the basement membrane (Lähteenmäki et al., 1995; Virkola et al., 1996;
Coleman et al., 1999; reviewed in Lähteenmäki et al., 2001). The surface-bound plasmin on S.
aureus also activates one of the major interstitial collagenases, matrix metalloprotease-1 (MMP-
1; Santala et al., 1999). The ability to lyse collagens could help S. aureus to penetrate through
ECM. The presence of Plg has been shown to increase transcytosis of S. aureus bacteria through
a monolayer of mammary epithelial cells (Zavizion et al., 1997). 
81.2.3. Regulation of virulence factors
The expression of surface-associated and secreted S. aureus exoproteins is controlled by a
complex regulatory network (reviewed in Novick, 2003). The best characterized part of this
network is agr (accessory gene regulator; Peng et al., 1988; Recsei et al., 1986). Two transcripts
are divergently produced from the agr locus promoters P2 and P3. Products of the P2 transcript,
AgrA, B, C and D, act as a two-component regulatory system: AgrD is processed and transported
out of the cell by AgrB. The processed peptide binds to the transmembrane AgrC causing its
autophosphorylation and leading to phosphorylation of intracellular AgrA. AgrA further activates
the promoters P2 and P3 (review: Novick, 2003). The transcript of P3, RNAIII, is the effector
upregulating genes of many extracellular proteins and downregulating genes of many surface
proteins by an as yet unknown mechanism (Novick et al., 1993). During in vitro growth most
surface proteins are best expressed in the early exponential phase. When the density of the culture
and the amount of RNAIII reach a certain level, at the post-exponential phase, secreted proteins
are induced and surface proteins down-regulated. Another, not so well characterized, two-
component system, SaeRS, upregulates the production of several secreted proteins (Giraudo et
al., 1994; Giraudo et al., 1999). A few transcription factors act in global regulation of virulence
factors. SarA (staphylococcal accessory regulator A) is a transcription factor upregulating
production of several surface proteins and is also required for the expression of agr (Cheung et
al., 1992; Cheung and Projan, 1994; reviewed by Novick, 2003). Rot (repressor of toxins),
another transcription factor, upregulates surface adhesin production and downregulates several
secreted proteins (McNamara et al., 2000; Saïd-Salim et al., 2003). Additionally, an alternative
sigma factor, Sigma B, is directly and indirectly, through SarA, involved in regulation of
virulence genes (Deora et al., 1997; Kullik et al., 1998).
1.3. S. aureus and cellular invasion
Traditionally, S. aureus has been considered as a strictly extracellular pathogen. In recent years,
increasing evidence has emerged on its ability to invade eukaryotic cells. It has been suggested
that cellular invasion is beneficial for the bacterium as it achieves protection from host defence
and antibiotics and reaches a nutrient-rich environment (Lowy, 2000). Most of the evidence is
from in vitro studies. However, in a chick embryo osteomyelitis model, bacteria were found either
in endosomes or free in the cytoplasm of osteoblasts 45 minutes after a subcutaneous and 48
hours after an intraallantoic S. aureus inoculation (Reilly et al., 2000). Also, in milk samples of
chronic bovine mastitis, living S. aureus bacteria were found in alveolar milk secreting cells and
macrophages (Hébert et al., 2000) and furthermore, dividing bacteria were found in experimental
mouse mastitis both free in the cytoplasm and associated with membranes in the mammary
epithelial cells (Brouillette et al., 2003a).
Internalization of S. aureus into nonprofessional phagocytic cells (epithelial cells, endothelial
cells, fibroblasts, bovine mammary gland cells) has been shown to depend on Fn-mediated
binding between the host cell and the Fn-binding proteins FnBPA or FnBPB on the surface of
staphylococci (Dziewanowska et al., 1999; Fowler et al., 2000; Lammers et al., 1999; Peacock
et al., 1999; Sinha et al., 1999). Multiple regions of the FnBPs, which are able to substitute for
each other, are involved, like in Fn adhesion (Massey et al., 2001). The specific molecule
involved on the host cell surface is integrin 51 (Fowler et al., 2000; Sinha et al., 1999).
Additionally, heat shock protein 60 (Hsp60) has been shown to directly bind FnBP and mediate
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molecules in addition to FnBPs nor bacterial activity is needed  for invasion since  FnBPA or B
expressed in Staphylococcus carnosus or Lactococcus lactis is enough to confer invasiveness, and
FnBP-coated polystyrene beads are internalized by epithelial cells (Sinha et al., 2000). Brouillette
et al. (2003a), however, showed that the internalization of the strain 8325-4 FnBP double mutant
into mammary epithelial cells was reduced but not abolished. Indeed, the secreted S. aureus
adhesin Eap (Table 1) was recently shown to mediate an alternative or parallel route for
internalization. The ability of an isogenic Eap-negative mutant of strain Newman to adhere to and
become internalized by fibroblasts and epithelial cells was impaired (Haggar et al., 2003). 
In the host cells,  internalization of staphylococci is an active cellular process dependent on actin
polymerization (Menzies and Kourteva, 1998; Sinha et al., 1999). Host cell tyrosine kinase
activity is required (Dziewanowska et al., 1999). More specifically, Src family protein-tyrosine
kinases have an essential role in internalization into epithelial cells and fibroblasts (Agerer et al.,
2003; Fowler et al., 2003). Internalization of living S. aureus cells is known to induce apoptosis
in human endothelial (Menzies and Kourteva, 1998) and pulmonary epithelial cells (Kahl et al.,
2000), as well as in bovine mammary epithelial cells (Bayles et al., 1998). Bacteria, which are
internalized in endosomes, can escape into the cytoplasm (Bayles et al., 1998; Menzies and
Kourteva, 1998) or replicate inside the endosomes (Kahl et al., 2000). S. aureus-infected human
endothelial cells have been shown to release cytokines IL-1 and IL-6 (Yao et al., 1995) and to
express adhesion molecules for monocytes and granulocytes (Beekhuizen et al., 1997). The
intracellular environment of endothelial cells increases formation of the so called small colony
variants (SCVs) of S. aureus. These mutants are defective in the biosynthesis of some electron
transport chain component and they can mutate back to the wild type. Formation of this kind of
slow growing mutants is also induced during prolonged antibiotic treatment. These mutants are
more difficult targets for antibiotics due to their low metabolic activity (Vesga et al., 1996).
Internalization of S. aureus bacteria into epithelial cells induces agr, the global regulatory system
of virulence factors. As a result, two peaks of RNAIII production are seen, the first one
temporally coinciding with the release of bacteria from endosomes into the cytoplasm, and the
second one with increasing of the host cell membrane permeability. The lysis of the endosomal
and cell membranes could result from RNAIII-induction of secreted proteins like - and -toxin
(Shompole et al., 2003). This suggests that the agr system can be induced by a single cell or a
small bacterial cluster in the microenvironment of an endosome or a host cell.
In conclusion, S. aureus seems to have an ability to invade various host cells. Whether this ability
actually contributes to pathogenicity or rather is a part of host defence, is still controversial. High
frequency of recurrent infections after antibiotic treatment and ability to metastasize from a local
infection site are in favour of a function beneficial for the bacteria (discussed by Lowy, 2000;
Sinha et al., 2000).
1.4. S. aureus infection models
Several in vivo models have been developed to study the pathogenic mechanisms of S. aureus and
the role of various virulence factors in these infections. If possible, a wild type strain has been
compared with an isogenic strain which has the studied (protein) molecule site-specifically
inactivated. Expression on the cell surface of a less virulent staphylococcal species or on avirulent
lactococci has been used to study the effect of specific components without compensatory effects
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of other S. aureus virulence factors. Effects of the S. aureus adhesins on virulence in various in
vivo models are shown in Table 1 and some of the models are described below.
1.4.1. Skin infections
S. aureus causes a wide variety of infections in many parts of the body, and different models are
needed to study them. Staphylococcal infections of skin are common and can be minor (e.g.
folliculitis or skin abscesses) or even life threatening (e.g. scalded skin syndrome). A murine
model where a suspension of microbeads carrying bacteria is injected subcutaneously has been
used to study cutaneous infections (Bunce et al., 1992). The formation of an abscess or
dermonecrosis is followed. 
1.4.2. Septic arthritis
Disruption of the protective skin or mucosal barriers can lead to access of bacteria to blood,
development of bacteremia. In circulation the bacteria can spread to various body sites and cause
infections. A serious disease usually starting from bacteremia is bacterial arthritis. It is a rapidly
progressive and highly destructive joint disease, the symptoms of which are caused by both
bacterial and host factors. In a well-established mouse model of staphylococcal septic arthritis
and sepsis (Bremell et al., 1991; Bremell et al., 1992) the bacteria are inoculated intravenously
corresponding to the most common hematogenous origin of human joint infections. Lower doses
of bacteria result in septic arthritis seen as swelling and redness as well as histopathological
changes and accumulation of phagocytic cells in the joints, whereas higher doses lead to sepsis
seen as decreased body weight, increased proinflammatory cytokine levels and bacterial growth
in the body (reviewed by Tarkowski et al., 2001). 
1.4.3. Endocarditis
Another severe condition caused by S. aureus is endocarditis, the risk of which increases if
cardiac valves are damaged mechanically or because of an inflammation. During a transient
bacteremia the bacteria attach to damaged valves where sterile vegetations formed by layered
blood components have built up. The bacteria colonize and grow or may be internalized by
endothelial cells. Bacteria may further spread to other organs (review: Moreillon and Que, 2004).
In experimental endocarditis a cardiac valve is artificially damaged mechanically by
catheterization (rabbit model: Durack and Beeson, 1972; rat model: Santoro and Levison, 1978)
or catheterized and damaged electrically (guinea pig model: Maurin et al., 1997) prior to an
intravenous bacterial inoculation. A primary adherence or endocarditis is measured as bacterial
titers in the vegetations after a shorter (e.g. 1 hour) or a longer (e.g. 1 to 2 days) incubation,
respectively. 
1.4.4. Osteomyelitis
Osteomyelitis, a progressive infection of bone, can result either from hematogenous spread of
infection, spreading from an adjacent infection focus or from a direct contamination e.g. in
surgery. It leads to an inflammation and growth of bacteria in the bone tissue, and deformation
of the bone. Osteomyelitis has been modelled e.g. in rabbit (Norden, 1970) and rat (Rissing et al.,
1985). In these experimental systems a bone defect is caused for example by drilling a hole in a
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bone. Bacteria are then inoculated either directly into the bone or hematogenously (e.g. Hienz et
al., 1995), which makes it possible to study the initial phases of osteomyelitis.
1.4.5. Pneumonia
S. aureus pneumonia can be caused by either an airborne or a hematogenous infection. In a rat
model of pneumonia bacteria are instilled into the airways of the animals, and lung injury and
bacterial survival are followed for a couple of days (McElroy et al., 2002). The hematogenous
infection is usually spread from an intravascular focus into the bloodstream. In a murine model
of hematogenous pneumonia staphylococci enmeshed in small agar beads are injected
intravenously. Bacterial survival and abscess formation in the lung is followed for a longer period
of time (Sawai et al., 1997).
1.4.6. Biomaterial related infections
In a hospital environment, S. aureus often causes biomaterial related infections. Implanted
medical devices easily become covered with host proteins. S. aureus cells attach to inert surfaces
or the covered surfaces with their array of adhesive molecules. A biofilm is formed, on both
artificial surfaces and on body surfaces, if the attachment is followed by growth-dependent
bacterial accumulation based on production of a slimy matrix and intercellular adhesion. Inside
the biofilm bacteria are better protected against host defence and antibiotic treatments (reviewed
by Götz, 2002).
1.5. Methicillin resistance
1.5.1. mecA
Methicillin resistance is primarily caused by the mecA gene encoding a 78-kDa penicillin-binding
protein 2A (PBP 2A or PBP 2´; Hartman and Tomasz, 1984; Matsuhashi et al., 1986; Ubukata
et al., 1985). S. aureus has four native PBPs, which are enzymes catalyzing transpeptidase and
transglycosidase reactions during peptidoglycan synthesis. -lactam antibiotics quickly acylate
these enzymes because of their structural similarity with the natural substrates of the PBPs. The
affinity of these antibiotics towards PBP2A is, however, much lower and this enzyme remains
functional. Actually, a partially functional native PBP in addition to PBP2A is needed in the
presence of -lactam antibiotics. The transglycosylase domain of the native PBP2 and the
transpeptidase domain of PBP2A cooperate in cell wall synthesis of MRSA (Pinho et al., 2001).
mecA is preceded by the regulatory genes mecR1 and mecI , which are transcribed to the opposite
direction as compared to mecA (Hiramatsu et al., 1992; Tesch et al., 1990). Mainly based on
homology to the plasmid-encoded penicillinase regulators BlaR1 and BlaI, which in addition to
regulation of penicillinase production are also able to regulate PBP2A production, MecR1 is
presumed to act as a signal transducer sensing the extracellular -lactam antibiotic. This leads to
activation of its cytoplasmic protease domain and specific cleavage of MecI, the transcriptional
repressor of mecA. In reality, most clinical MRSA isolates have deletions or point mutations in
the regulatory area and they constitutively produce PBP2A. Intact regulator genes strongly
repress PBP2A production, and it is poorly inducible even in the presence of many -lactam
antibiotics, including methicillin.
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1.5.2. SCCmec
mecA is a part of a chromosomal staphylococcal cassette chromosome mec (SCCmec) region,
which is not present in methicillin sensitive Staphylococcus aureus (MSSA). SCCmec forms a
genomic island which is inserted into S. aureus chromosome near to the origin of replication at
a well conserved attBscc site in the orfX gene of unknown function. The 15 bp att sequence is
also present in the SCCmec region. After integration this sequence is found as direct repeats at
both ends of SCCmec. In addition, degenerate inverted repeats are found at the ends of the
SCCmec (Ito et al., 1999). 
Five types of SCCmec have been characterized so far (Figure 2; Daum et al., 2002; Ito et al.,
1999; Ito et al., 2001; Ito et al., 2004; Ma et al., 2002).  Each type contains a mec gene complex
with the resistance encoding mecA gene and intact or partly deleted regulatory genes. The region
also contains a cassette chromosome recombinase (ccr) gene complex encoding site-specific
recombinases of the invertase/resolvase family, which are responsible for integration and excision
of SCCmec, as well as additional type specific DNA. Type I SCCmec possesses a so called class
B mec complex: IS431-mecA-mecR1-IS1272, and the ccr genes A1 and B1. Type II SCCmec
contains a class A mec complex: IS431-mecA-mecR1-mecI, and ccr genes A2 and B2. Type III
SCCmec has the class A mec complex with ccrA3 and B3, while type IV SCCmec has the class
B mec complex with ccrA2 and B2 genes. The recently found type V SCCmec has a class C2 mec
complex: IS431-mecA-mecR1-IS431, and a single ccr gene designated C. The enzymes encoded
by ccrA and B genes together, and by ccrC on its own are able to catalyze the precise excision
and integration of the SCCmec element (Ito et al., 2004; Katayama et al., 2000). 
Type I, IV and V SCCmec elements carry no other resistance genes in addition to mecA. Type II
and III SCCmec elements carry resistance for spectinomycin and erythromycin encoded by
Tn554. In addition, resistance for tobramycin, kanamycin and bleomycin, encoded by pUB110,
are carried by type II SCCmec. Tn554 codes for cadmium resistance and pT181 for tetracyclin
resistance. Both of these as well as mercury resistance are carried by type III SCCmec. Type II
and III elements contain several copies of IS431 sequences in addition to those associated with
the mec complex. These insertion sequences flank the plasmids integrated in SCCmec. pls gene,
the topic of this thesis, is a part of type I element, whereas the type II element carries genes
homologous to kdp operon encoding ATP-dependent potassium transport across the bacterial
membrane. Type V element carries hsd genes encoding for a restriction-modification system. 
CcrB1 gene in the studied MRSA strains (Ito et al., 2001) has a frameshift mutation that prevents
spontaneous excision of type I SCCmec. A functional ccrB1 gene has, however, been found in
the genome of Staphylococcus hominis type strain GIFU12263. It was part of a  mecA deficient
SCC element capable of mobilization (Katayama et al., 2003). SCC elements without the mecA
gene have recently been found in both S. aureus and coagulase negative staphylococci. These
elements are inserted in the chromosome at the same site as SCCmec and have either functional
ccr genes identical or slightly different from the ones found in SCCmec, or nonfunctional gene
areas resembling the ccr genes. Type 1 capsule genes of S. aureus strain NCTC8325 are carried
in the SCCcap1 defective in mobilization (Luong et al., 2002). A putative fusidic acid resistance
determinant and type I restriction modification system genes are carried in SCC476 element of
the strain MSSA474 (Holden et al., 2004). S. epidermidis strain 12228 has heavy metal resistance
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Figure 2.  Types of staphylococcal cassette chromosome (SCCmec) regions that have been characterized. The mec
gene complex containing mecA and regulatory genes is drawn in red, the cassette chromosome recombinase (ccr)
gene complex in yellow. Insertion sequences are drawn in blue or orange, transposon Tn554 and areas surrounding
it and homologous between the types in green, SCCmec type specific genes in gray. orfX, a gene of unknown
function containing the insertion site for SCCmec. Type I, strain NCTC10442 (Ito et al., 2001); Type II, strain N315
(Ito et al., 1999); Type III, strain 85/2082 (Ito et al., 2001); Type IV, strain 8/6-3P (Ma et al., 2002); Type V, strain
WIS (Ito et al., 2004).
genes and three IS431 sequences in its SCC-CI element. Additionally, a smaller SCC element is
located inside this SCC-CI element (Mongolrattanothai et al., 2004). All these findings have led
to the idea that SCC elements serve as vehicles for transfer of genetic information between
staphylococcal strains and species.
1.5.3. Other genes affecting methicillin resistance
Fem (factor essential for methicillin resistance) or aux (auxiliary) genes are normal chromosomal
genes of both MRSA and MSSA strains and their products affect formation of peptidoglycan
precursors. Defective building blocks in fem mutants are not optimal substrates for PBP2A and
lead to reduced resistance (reviewed in Berger-Bächi, 1994; Chambers, 1997; de Lencastre et al.,
1994). In addition to fem genes, the genes llm (Maki et al., 1994), fmtA (Komatsuzawa et al.,
1997), fmtB which encodes an LPXTG-protein of unknown function (Komatsuzawa et al., 2000)
and sigB gene cluster coding for an alternative sigma factor (Wu et al., 1996) affect the level of
methicillin resistance.
1.5.4. Evolution of MRSA
1.5.4.1. The origin of mecA
It has been thought that the mecA gene was acquired from an extraspecies source by S. aureus.
In a study of over 200 staphylococcal strains of different species a close homologue of mecA was
found in each one of the 134 independent Staphylococcus sciuri isolates studied, whereas in other
species a homologue was found in rare cases only (Couto et al., 1996).The majority of S. sciuri
strains are, however, methicillin sensitive. The strains resistant to methicillin usually have two
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copies of mecA, one being the S. sciuri mecA homologue and the other a mecA gene from S.
aureus. The mecA of S. sciuri may be a native genetic element with an unknown physiological
function (Couto et al., 1996). The deduced amino acid sequences of mecA of MRSA and its S.
sciuri homologue have an overall similarity of 88%. The transpeptidase domains show a
similarity of 96% and the transglycosylase domains a similarity of 80% (Wu et al., 1996). The
idea that the S. sciuri mecA homologue may be an evolutionary precursor of the mecA in MRSA
was supported by a recent study where exposure of an S. sciuri strain to increasing concentrations
of methicillin was shown to activate the S. sciuri mecA homologue by causing a point mutation
in the promoter area. This mutated gene resulted in methicillin resistance in S. sciuri and when
it was transduced to S. aureus (Wu et al., 2001). S. sciuri is considered one of the most ancestral
staphylococcal species (Kloos et al., 1976; Kloos et al., 1997). It is widely distributed in nature
and it is part of the normal flora of the skin in many lower mammals (Couto et al., 1996; Kloos
et al., 1997). It is occasionally isolated from human samples as well (e.g. Marsou et al., 1999;
Nagase et al., 2002), but only rarely is it associated with infections (e.g. Hedin and Widerström,
1998; Horii et al., 2001; Shittu et al., 2004; Stepanovi et al., 2002).
1.5.4.2. The clonality and spread of MRSA strains
Epidemic MRSA strains in hospitals are usually clonal in origin. There are only a few pandemic
MRSA clones, the so called Iberian, Brazilian, Hungarian, New York/Japan, Pediatric and
EMRSA-16 clones, named after the geographical area where they were first identified or some
epidemiological characteristic. The strains of these successful lineages are responsible for most
of the hospital-acquired MRSA infections all over the world today (reviewed by Oliveira et al.,
2002). According to a study by Crisóstomo et al. (2001), the first MRSA strains and the MSSA
strains which were isolated at the same time, around the year 1960 in United Kingdom and
Denmark, have similar genetic backgrounds. These so called "archaic" MRSA carrying type I
SCCmec are also very similar to contemporary isolates of the "Iberian" clone (Crisóstomo et al.,
2001). 
There are numerous methods used for molecular typing of MRSA strains. Pulsed-field gel
electrophoresis (PFGE) is the most common method used in clinical laboratories for typing. For
global epidemiological or evolutionary studies sequencing-based methods like multilocus
sequence typing (MLST) are the most suitable. Recent studies based on characterization of both
the SCCmec type and the genetic background of the strain with MLST, internal sequencing of
seven housekeeping genes, and sequencing of fragments of seven S. aureus surface protein genes,
have improved the evolutionary analysis. There have been estimates on how many times an
MRSA strain was born during the history. These studies suggest that the clones of major MRSA
lineages have evolved by an MSSA or a MRSA strain acquiring an SCCmec element at least 20
times altogether (Enright et al., 2002; Robinson and Enright, 2003). Transfer of an SCCmec
element thus seems to be a rather rare event.
Differently from the pandemic clones, minor clones dominant in single hospitals and sporadic
isolates from a few patients only seem to have a much more diverse genetic background and
variation of SCCmec elements (de Sousa and de Lencastre, 2003). Also community-acquired
MRSA are much more diverse genetically. Most often they carry a type IV SCCmec element.
This element is small compared to the other SCCmec elements and it has been suggested to have
a smaller biological cost as compared to the larger elements in environments where multidrug
resistance is not beneficial (de Sousa and de Lencastre, 2003; Ma et al., 2002).
15
2. AIMS OF THE STUDY
The background of this study is in clinical diagnostics: a group of MRSA, which were not
agglutinating in rapid S. aureus identification tests, were found to have an extra band in SDS-
PAGE analysis of their solubilized surface proteins (Kuusela et al., 1994). The non-agglutinating
phenotype raised a question on the effect of this additional protein on bacterial adhesion to host
molecules important in the initiation of an infection. 
The first aim of this work was to isolate and characterize this protein and its gene. Predicted
amino acid sequence of the novel protein, Pls, revealed a structural organization typical to
adhesins of Gram-positive bacteria. The second aim then became to examine the function of Pls,
especially in adherence. For this purpose, a Pls deficient site specific mutant strain was
constructed and analyzed for adhesiveness and host cell invasiveness. The third aim was to study
whether Pls had an effect on MRSA virulence by using a well-established mouse model of septic
arthritis. The pls gene was associated with mecA encoding methicillin resistance in the MRSA
genome. More sequence data on the genomic region surrounding mecA in S. aureus came
available during this thesis work, and the fourth aim of this study became to examine the presence
and expression of Pls in S. sciuri, the species suggested as the origin of mecA. 
This study was performed out of scientific interest in the pathogenesis of S. aureus, but also
keeping a diagnostic and therapeutic point of view in mind, since the target of the study, MRSA,
is one of the most common hospital pathogens especially problematic because of its resistance
to antibiotics.
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3. MATERIALS AND METHODS
The bacterial strains used in this study are listed in Table 2. The methods are described in detail
in the original publications and are summarized in Table 3.
Table 2. Bacterial strains used in this study
Bacterial strain Properties Used in Reference or source
Staphylococcus aureus, MRSA
1061 Pls+, Finnish clinical isolate I, II, III, IV, V Kuusela et al., 1994
1061 pls::TcR Pls- II, III, IV This study
1061 pls::TcR (pPLS4) Pls+ II, III, IV This study
658, 3560, 4210, 5118 pls+, Finnish clinical isolates III Kuusela et al., 1994
3707, 1231, 4830, 6027,
6092
pls-, Finnish clinical isolates I, III Kuusela et al., 1994
A880510, A900159,
A900557, A910071,
A920096
pls+, French clinical isolates II, III J. Étienne, Centre National de
Référence Staphylocoques,
Lyon, France
8 undesignated MRSA
strains
Swiss clinical isolates III B. Sinha; University Hospitals
of Geneva, Switzerland
Iberian, UK-EMRSA-
16, Brazilian, Helsinki
IV
Epidemic strains with a specified
SCCmec type
V National Public Health Institute,
Helsinki, Finland
BB270 mec(EK142) transduced into BB255 II Beck et al., 1986
Staphylococcus aureus, MSSA
BB255 Derivative of 8325 II Berger-Bächi, 1983
20 undesignated MSSA
strains
isolates from the nares of healthy
carriers (7) and patients with
osteomyelitis (4) or endocarditis (9)
III J. Schrenzel; University
Hospitals of Geneva,
Switzerland
Cowan1 septic arthritis isolate I, III ATCC 12598
Newman high-level ClfA producer II, III ATCC 25904; Duthie and
Lorenz, 1952
RN4220 Restriction-deficient mutant of 8325-
4 capable of stable maintenance of
shuttle plasmids
II Kreiswirth et al., 1983
Staphylococcus  sciuri
N900109, N930262, S
2832j, S 29, N920212,
N960546, N970234,
N950282
clinical isolates, ssp. sciuri V J. Étienne, Centre National de
Référence Staphylocoques,
Lyon, France; Marsou et al.,
1999
N900165, S A8b,
N900228, S 106j,
N950120
clinical isolates, ssp. rodentium V -"-
N960509, N970555 clinical isolates, ssp. carnaticus V -"-
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Staphylococcus epidermidis
N860348, N860187,
Hall, 190
Clinical blood isolates from
endocarditis patients
III J. Étienne, Centre National de
Référence Staphylocoques,
Lyon, France; Étienne and
Eykyn, 1990
Staphylococcus carnosus
TM300 No expression of known adhesins III Schleifer and Fischer, 1982
Escherichia coli
LE392 Host for cosmid library II Sambrook et al., 1989
XL1Blue MRF´ Cloning host II Stratagene
Table 3. Methods used in this study
Method Described and used in
Genetic methods 
Molecular cloning techniques in E. coli and S. aureus (cloning of pls) II
DNA sequencing II
Mutagenesis by allelic replacement II
Dot blot hybridization II, V
Southern hybridization II, III, V
Repeat region size analysis by PCR II, V
Pulsed-field gel electrophoresis II, III, V
Sequence analysis by computer II
Protein work
SDS-PAGE I, II, III, V
Periodate/Schiff´s reagent staining of glycoproteins I
Pls purification by gel filtration, ion exchange and hydrophobic interaction chromatography I
Pls purification by affinity chromatography I, IV, V
Amino acid sequencing I, II
Surface labelling of bacteria I
Lysostaphin extraction of surface proteins I, II, III, V
Digestion of bacteria with trypsin or plasmin I
Plasminogen activation on bacterial surface I
Lectin binding assays on nitrocellulose membranes and microtiter plates I
Purification of IgG and production of Fc fragments II, III
Immunological methods
Production of polyclonal antibodies to Pls I, II
Production of monoclonal antibodies to Pls III
Western blotting I, II, III, V
Ligand blotting II, III
Adhesion assays
Adhesion of bacterial cells to immobilized host proteins I, II, III
Binding of soluble 125I-labelled proteins to bacterial cells III
Invasion assays
Bacterial invasion of 293 human kidney cells III
Methods used in animal studies
Visual evaluation of arthritis and general health state IV
Measurement of body weight IV
Microscopic examination of histological joint sections IV
Viable count of S. aureus from joints, kidneys and blood IV
Cytokine measurements IV
Statistical analysis III, IV
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4. RESULTS AND DISCUSSION
The starting point for this study was the problem that some MRSA strains (2-30 % of MRSA as
reported by Berke and Tilton, 1986; Kuusela et al., 1994; Piper et al., 1988; Ruane et al., 1986)
failed to be detected as S. aureus in commercial rapid identification tests commonly used in
clinical laboratories in the 1980s and in the beginning of the 1990s. Later in the text these strains
will be called "agglutination negative" strains. In these tests bacteria were mixed with
erythrocytes or latex particles coated with Fgen and/or IgG. The positive reaction was
agglutination based on interaction of Fgen and IgG with the S. aureus surface Fgen-binding
proteins and protein A (SpA), respectively. Studies in our laboratory had shown that the
agglutination negative MRSA strains expressed, most probably on their surface, a large 230-kDa
protein and a smaller 175-kDa protein which could not be found in the MRSA strains giving a
positive result in these agglutination tests ("agglutination positive" strains; Kuusela et al., 1994).
Later on, the 175-kDa protein was shown to arise from the 230-kDa one, and the protein was
named Pls, for plasmin sensitive.
4.1. Purification and characterization of Pls (I, II)
Pls was equally expressed at all growth phases in vitro (unpublished, K. Juuti & P. Kuusela),
differently from many S. aureus surface proteins, which are preferentially expressed during the
early exponential growth phase. Pls was purified from a surface protein extract of an
agglutination negative clinical MRSA strain 1061 by treating the cells with lysostaphin and by
using consecutive chromatographies based on gel filtration, ion exchange and hydrophobic
interactions. This resulted in purification of 230-, 175- and 68-kDa polypeptides. An alternative
purification procedure, wheat germ agglutinin (WGA) affinity chromatography of the lysostaphin
extract, resulted in detection of 230- and 175-kDa bands in an SDS-polyacrylamide gel
electrophoresis (SDS-PAGE; I/Fig. 1). Thereafter, the affinity chromatography was always used
for Pls purification (II, IV, V). Treatment of bacterial cells with trypsin or plasmin resulted in a
decrease in the amount of the 230-kDa band and an increase in the amount of the 175-kDa band
in an SDS-PAGE of lysostaphin extracts. Earlier findings in the laboratory had shown that
plasmin activity could be produced on bacterial surface by incubating the cells with soluble
plasminogen and its activator tPA, and that this enzymatic activity was protected against
physiological plasmin inhibitor 2-antiplasmin (Kuusela and Saksela, 1990). This surface-bound
plasmin also resulted in a similar increase of the 175-kDa band and disappearance of the 230-kDa
band (I/Fig. 6). It has been shown that plasmin bound on bacterial surface gives the cells an
ability to cleave surrounding ECM components (Coleman et al., 1999; Lähteenmäki et al., 1995;
Virkola et al., 1996). Our results indicate that the proteolytic activity of surface-bound plasmin
can also be targeted towards the bacterial cell surface proteins. Because of this finding the 230-
kDa protein was given the name Pls, plasmin sensitive. 
Evidence that Pls is surface located came from iodine labelling of whole bacterial cells: the 230-
and 175-kDa bands, possibly also the 68-kDa band, were seen in autoradiography of a lysostaphin
extract (I/Fig. 6C). Additionally, an antiserum was produced against an agglutination negative
MRSA strain and Pls-specific antibodies purified from it using adsorption to the 230-kDa Pls
protein band transferred to a nitrocellulose membrane. These antibodies could agglutinate cells
of agglutination negative MRSA strains (Kuusela et al., 1994). The same antibodies recognized
the 175-kDa band in addition to the 230-kDa protein in immuno-blotting analysis, further
19
suggesting that the 175-kDa protein arised as a cleavage product of the 230-kDa protein (Kuusela
et al., 1994). The tryptic peptide maps of the 175-kDa protein and the combined 230-, 175- and
68-kDa peptides were also very similar (I). Amino acid sequences of tryptic peptides of the 175-
kDa protein did not match those of any known protein suggesting that Pls was a novel protein (I).
N-terminal sequencing of the 230-kDa Pls was not successful. In paper II the N-terminus of 175-
kDa peptide originating from a lysostaphin digest of strain 1061 was sequenced. The sequence
AAQDT indicated a cleavage site by an unknown activity in the predicted amino acid sequence
(based on pls DNA sequence, see chapter 4.2.) between the amino acids 387R and 388A and
confirmed that the 175-kDa peptide was part of the 230-kDa peptide (II). Three other S. aureus
surface proteins, ClfA (McDevitt et al., 1995), ClfB (McAleese et al., 2001) and SasA (Roche
et al., 2003a) are cleaved at a specific site in their A regions during in vitro culture. In ClfB the
metalloprotease aureolysin is responsible for the cleavage which leads to the loss of Fgen binding
ability (McAleese et al., 2001). A specific proteolytic cleavage thus seems to be a feature shared
by several LPXTG proteins. 
The affinity purification of Pls on WGA was made possible by a carbohydrate portion tightly
associated to Pls. Binding of Pls by several lectins was therefore tested. WGA, which binds to
N-acetyl-D-glucosamine (GlcNAc) and sialic acid, was the only studied lectin that bound to
purified Pls in ligand blotting and modified ELISA assays. It was found that WGA binding
carbohydrates are present in the 175-kDa cleavage product but not within the 68-kDa peptide
apparently representing the N-terminal part of Pls, since this fragment was not purified in the
affinity chromatography (I/Fig. 1). The 230- and 175-kDa Pls bands were also the main peptides
in a periodate/Schiff´s reagent staining of a lysostaphin extract of the strain 1061 (I/Fig. 5B). 
Glycoproteins are not commonly found in bacteria. The first glycosylated prokaryotic proteins
found were surface (S-) layer proteins in archae and bacteria (reviewed in Messner and Sleytr,
1991). Later on, glycosylated flagellins and fimbrial proteins, as well as other cell-associated or
secreted proteins have been described (reviewed e.g. in Schmidt et al., 2003; Upreti et al., 2003).
The presence of the carbohydrate portion in Pls after the denaturing SDS-PAGE suggests a
covalent linkage. There is a possibility that Pls carbohydrates originate from non-proteinaceous
structures of the cell wall. GlcNAc is one of the main components in peptidoglycan. S. aureus
wall teichoic acids usually consist of ribitol phoshates substituted with GlcNAc and D-alanine
and are attached to the peptidoglycan sugar chains (Endl et al., 1983; Neuhaus and Baddiley,
2003; Weidenmaier et al., 2004). Because Pls is an LPXTG protein (II) and thus linked to the
peptidoglycan pentaglycin bridges, and because lysostaphin digests the pentaglycin bridges
(Browder et al., 1965; Zygmunt et al., 1967), it is theoretically not very probable that a
lysostaphin extract would contain GlcNAc from peptidoglycan or teichoic acids. In practice, some
cells may be lysed during the preparation of a lysostaphin extract, releasing all kinds of cell
surface components. If large pieces of cell wall were attached to the extracted proteins we would
probably see carbohydrates associated to many proteins in the extracts, which now was not the
case. Thus, it seems probable that Pls is a true glycoprotein.
4.2. Cloning and sequence analysis of pls (II)
The pls gene was cloned from the clinical MRSA strain 1061 (II). A cosmid library of total DNA
was constructed, and screened using degenerate oligonucleotides designed based on the internal
tryptic peptides sequenced in paper I. Subcloning, chromosome walking and generation of
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exonuclease deletion series resulted in the sequence of the 4914 bp pls and its 453 bp 5´ and 235
bp 3´ flanking regions (GenBank database accession number AF115379). 
The predicted 1637 aa Pls sequence contained a putative signal sequence of 48 aa in the N-
terminus and an LPDTG sequence followed by hydrophobic residues and positively charged
amino acids in the C- terminus (II/Fig. 1). The C-terminus was thus similar to the LPXTG
proteins common in S. aureus and other Gram-positive bacteria (Figure 1; Fischetti et al., 1990).
The sortase enzyme is known to cut this type of proteins between threonine and glycine in the
LPXTG sequence and to attach them in the cell wall, thereby exposing the major N-terminal part
of the protein on the cell surface (Navarre and Schneewind, 1994). The calculated molecular mass
of Pls was 175 kDa. Its movement in SDS-PAGE suggests a larger apparent size of about 230
kDa. A size discrepancy like this has been seen in many surface proteins of Gram-positive
bacteria (e.g. McDevitt et al., 1994). In this case the size difference could be partly due to the
carbohydrate containing portion associated with Pls (I). That pls is not a part of an operon but a
single gene, was suggested by a putative upstream ribosome-binding site AGGGG and by a
downstream palindromic sequence that could be a transcription terminator (II). Another putative
ribosome-binding site followed by a new start codon was located nearby in the 3´ direction of pls.
A remarkable feature of the predicted sequence are the three repeat regions (II/Fig. 1). The most
C-terminal one is a serine-aspartate (SD) dipeptide repeat of 282 aa. This kind of a repeat is found
in several other S. aureus surface proteins (SD repeat proteins) with an LPXTG sequence (see
Figure 1 and Introduction). In ClfA the repeat has been shown to function as a spacer arm
displaying the N-terminal Fgen-binding part of the molecule at a right position on the cell surface
(Hartford et al., 1997). SD repeat proteins have also been described in coagulase-negative
staphylococcal species. The Staphylococcus epidermidis protein Fbe has an SD repeat and binds
fibrinogen with it's a region (Nilsson et al., 1998). SdrF and SdrG of S. epidermidis have a
structure very similar to S. aureus SdrC, SdrD and SdrE with B repeats between the A and R
regions. SdrG is very similar to Fbe. SdrH of S. epidermidis lacks the LPXTG motif and the B
repeats but the SD repeat is followed by an additional unique region (McCrea et al., 2000).
Recently, an SD repeat protein SdrX was identified in Staphylococcus capitis strains which often
are responsible for hospital infections in neonates. The A region of SdrX was shown to mediate
binding to human collagen type VI (Liu et al., 2004). Additionally, two genes encoding SD repeat
proteins have been cloned from Staphylococcus caprae (sdrY and sdrZ, GenBank accession
numbers AY048593 and AY048595), and one from Staphylococcus saprophyticus (sdrI,
accession number AF402316). 
The most N-terminal repeat region of Pls consists of 14 repeats of 12 to14 aa (II/Fig. 1), and the
third repeat region of four consequent 128 to129 aa stretches and an additional 36 aa fragment
of a fifth stretch. The repeat areas have been designated as R1, 2 and 3 starting from the most N-
terminal one (II/Fig. 1). According to the nomenclature now commonly used (after publication
of paper II)  for the SD repeat proteins (e.g. Roche et al., 2003a) it is more appropriate to use the
name A for the R1 and the following unique region, the name B repeats for the R2 region, and
the name R for the R3 region (Figure 1). 
The apparent size of Pls varies between different strains. PCR analysis of pls in six MRSA strains
revealed that this is due to variation in the sizes of all the three repeat regions, whereas the size
of the unique region was constant (II/Fig. 2). Similarly, McDevitt and Foster (McDevitt and
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Foster, 1995) showed for ClfA that the length of the SD repeat varies between the strains while
the length of the A region is constant. The outermost repeats in each repeat region of Pls differed
more from the consensus DNA sequence than the middle ones. There might be homologous
recombination going on among repeats of a single region or homologous regions of different S.
aureus surface molecules. In an individual strain, however, no changes in the lengths of the
repeats were induced during 19 repeated rounds of cultivation (II). The sizes of the repeats were
thus found to be quite stable. 
Apart from the SD repeat area, Pls has only low similarity to the other SD repeat proteins. Pls has
an overall amino acid sequence identity of 39 % with the S. epidermidis protein Aap
(Accumulation associated protein) involved in biofilm formation on glass or polystyrene surfaces
(GenBank accession number AJ249487; Hussain et al., 1997). The highest local similarity to Aap
is in the B repeats with 63-73 % identity between individual repeats. A 65 % identity is found
between the B repeats of Pls and a newly described S. aureus LPXTG protein SasG (Figure 1)
(Roche et al., 2003b). Also, a 217 aa area in the C-terminal end of the Pls A region is homologous
to a corresponding area in Aap, SasG and SasA (e.g. a 52 % identity between the homologous
areas in SasG and Pls; Roche et al., 2003a).  
4.3. Pls is part of the type I SCCmec (II)
All the S. aureus strains where we have found pls have been methicillin-resistant. In PFGE
analysis of SmaI digested MRSA strain 1061 DNA, pls and mecA probes hybridized with the
same 190-kb fragment (II/Fig. 3). Furthermore, a transduction of the MRSA strain EK142 mecA
gene to an MSSA strain (Beck et al., 1986) had also brought the pls gene to this strain (II/Fig. 3).
These results suggested that the pls gene was closely associated with the mecA gene. At that time,
the SCCmec region sequence of strain NCTC10442, the first MRSA strain ever isolated, had just
become available, as well as an unfinished genome sequence of the MRSA strain COL. Both of
these sequences contained a gene homologous to pls of strain 1061 at a distance of about 15.5 kb
from mecA. Later on, it was published that mecA is part of a staphylococcal cassette chromosome
mec (SCCmec), a genomic island capable of integration and excision at a specific chromosomal
site (Ito et al., 2001). So far, five types of SCCmec have been described  (Figure 2; Daum et al.,
2002; Ito et al., 1999; Ito et al., 2001; Ito et al., 2004; Ma et al., 2002), with pls being a part of
the type I SCCmec. Type I SCCmec may not be excised and integrated easily since one of its
recombinase genes, ccrB1, is truncated and cannot catalyze excision or integration (strain
NCTC10442; Ito et al., 2001). This may lead to a slower spread of type I SCCmec elements but
also to a better stability, even in the absence of an antibiotic selection pressure.
4.4. Construction of an allelic replacement pls mutant strain and its complementation (II)
An allelic replacement mutant of pls was constructed into the chromosome of the MRSA strain
1061 (II). A part of pls gene interrupted by a tetracyclin resistance encoding gene was introduced
into the strain 1061 in a temperature sensitive shuttle plasmid and a stable 1061 pls::TcR mutant
was obtained as a result of homologous recombination. The mutant strain was complemented
with a shuttle plasmid containing the PCR amplified strain 1061 pls with its putative promoter
and transcription terminator regions in a shuttle plasmid (II). Pls was not expressed by the 1061
pls::TcR strain whereas the complemented strain 1061 pls::TcR (pPLS4) expressed it even more
strongly than the wild type strain 1061 (II/Fig. 4C). Pls from the complemented strain also had
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a carbohydrate containing portion and could be affinity purified with immobilized WGA.
4.5. Effects of Pls on bacterial adhesion
4.5.1. Adhesion assays using clinical Pls+ and Pls- isolates (III)
Because this study started from the observation that the agglutination negative MRSA strains
expressed Pls on their surface, we wanted to examine adherence of these strains to immobilized
Fgen and IgG in more detail. Indeed, it was found that the Pls+ MRSA strains adhered less
efficiently not only to human Fgen and rabbit IgG but also to human Fn and mouse laminin
immobilized on glass slides, compared to the Pls- MRSA strains or the MSSA strain Cowan1,
which was used as a control (III/Fig. 4). Knowing that hospital MRSA isolates have a high
probability to be clonal (Oliveira et al., 2001), a genomic PFGE analysis was performed and
strains identical with each other were excluded from the study. In addition, binding of soluble 125I-
labelled Fn, Fgen and IgG to the strains was studied. The Pls+ MRSA strains bound soluble Fn
and Fgen less effectively than the Pls- MRSA or the MSSA control strains. Binding of soluble
IgG, however, was efficient among both groups (III/Fig. 5). Subsequently, expression of some
of the surface adhesins involved was analyzed.  The expression of ClfA, one of the Fgen-binding
proteins, was studied using Western blotting with a specific antibody. The Pls- strains showed
good expression, whereas most of the Pls+ MRSA strains, including the strain 1061, expressed
ClfA poorly or not at all, even though all the studied strains had the clfA gene. Fn-binding
proteins, which were studied using a ligand overlay assay of lysostaphin extracts, were equally
expressed by the Pls+ and Pls- MRSA strains. SpA expression, which was studied by using a
specific antibody, did not differ between the groups. There were strains with low expression in
both groups, which explains well the differences in IgG binding between individual strains.
(III/Table 2). The difference in ClfA expression could at least partly explain the difference in
Fgen adhesion between the groups, whereas the differences between Pls+ and Pls- MRSA in Fn
and IgG binding could thus not be explained by differences in expression of the adhesins. The
molecular biology of staphylococcal laminin binding is not well characterized and the basis of
the adhesion difference between the groups was not studied. 
4.5.2. Adhesion assays using MRSA strain 1061 and its isogenic Pls- mutant (II, III)
The effect of Pls on the differences in adhesion was confirmed by using the strains 1061, 1061
pls::TcR and 1061 pls::TcR (pPLS4). The adherence of strain 1061 to immobilized Fn and IgG or
its Fc fragments was very low compared to that of the strain 1061 pls::TcR . The wild type strain
did not adhere to immobilized Fgen at all and the mutant strain did so at a very low level. Neither
of the strains adhered to laminin. The strain 1061 pls::TcR (pPLS4) behaved like the wild type
strain except for Fn adherence, which was not reverted to the low wild type level but rather stayed
at a high level. (II/Fig. 5 and III/Fig. 4). Soluble Fgen was bound poorly by all the three strains.
There was no difference between the strains in binding of soluble Fn which was bound at a
moderate level, and IgG which was bound effectively (III/Fig. 5).The poor binding of Fgen could
again at least partly be explained by the poor ClfA expression by the strain 1061. SpA and Fn-
binding proteins were expressed by the strain 1061. 
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4.5.3. Pls as an anti-adhesin
Based on these results, the hypothesis is that Pls has a general effect on adhesins. It prevents
adhesion to host ligands by an as yet unknown mechanism. Adhesion to immobilized but not to
soluble IgG is prevented, suggesting a mechanism based on steric hindrance: SpA on the bacterial
surface might be accessible for IgG in a soluble form but not for the immobilized IgG on surfaces
of glass slides or latex particles, which were used in the agglutination tests. The Pls+ strains in our
study expressed ClfA poorly and thus we were unable to confirm the effect of Pls on Fgen
adhesion. Evidence for an effect on Fgen adhesion comes from an earlier study. Vaudaux et al.
(Vaudaux et al., 1998) transduced the mecA gene of MRSA strain EK142 to an MSSA strain
derived from strain 8325. We showed that the pls gene was co-transduced to this strain (II/Fig.
3). The transductant strain BB270 showed an impaired adherence ability to immobilized Fn and
Fgen even if the adhesin expression levels were not changed (Vaudaux et al., 1998). Recently,
another S. aureus LPXTG protein, SasG, homologous to Pls in the C-terminal part of it’s a region
(Figure 1), was shown to reduce adherence of S. aureus cells to immobilized Fn and Fgen as well.
SasG was expressed at a very low, undetectable, level in vitro, and the adherence studies were
performed by expressing SasG from an expression vector (Roche et al., 2003b). Yet another S.
aureus LPXTG protein, Bap (biofilm-associated protein, Figure 1, Table 1), has been shown to
cause anti-adhesiveness. Bap has been identified only in strains that cause mastitis in cows and
it decreases adherence of S. aureus cells to Fn and Fgen (Cucarella et al., 2002).
4.5.4. Pls as an adhesin
Our finding that complementation of the pls::TcR mutation by pls in a plasmid failed to restore
Fn adherence to the low wild type level, is difficult to explain. Pls expression by the
complemented strain is slightly higher than expression by the wild type strain. Pls has been
reported to promote bacterial cell-cell interactions as soluble Pls incubated with MRSA cells
induced aggregation (Huesca et al., 2002). Cells of a Pls deficient strain aggregated more strongly
than cells of a Pls expressing strain, indicating that the intercellular binding was not based on Pls
binding to Pls but to some other molecule on the bacterial surface. In addition, soluble Pls
increased adhesion of MRSA cells to immobilized Fn, Fgen, IgG and mucin, which was proposed
to result from the increased intercellular binding (Huesca et al., 2002). The overexpression of Pls
in the complemented 1061 pls::TcR (pPLS4) strain might have a similar adhesion increasing
effect.
Huesca et al. (2002) also showed that Pls is able to adhere to cellular lipids. Purified Pls and a Pls
expressing MRSA strain bound to several glycolipids and phospholipids whereas a closely related
but non-isogenic Pls- strain did not bind any of them.
Anterior nares are known to be the primary reservoir of S. aureus in humans. Interestingly, recent
results by Roche et al. (2003b) gave evidence that Pls might be involved in attachment to host
cells. They showed that Pls and SasG promote adherence to human desquamated nasal epithelial
cells. Adherence of SasG expressing bacteria could be inhibited by incubating the epithelial cells
with purified recombinant A regions of SasG, Pls or Aap from S. epidermidis. The homologous
area in these proteins is located at the C-terminal part of the A region. This C-terminal area was,
however, not enough for the inhibition but the whole A region was needed (Roche et al., 2003b).
The target molecule on the epithelial cell surface has not been determined yet. The ability to
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specifically bind nasal epithelial cells suggests that all of these proteins could be involved in nasal
colonization and thus in maintaining a carriage state and keeping up a reservoir of S. aureus
among the human population. 
4.5.5. Effect of plasmin treatment on the adherence of MRSA strain 1061 (I)
In publication I, it was shown that the full length 230-kDa Pls is cleaved to a smaller 175-kDa
polypeptide when cells of the MRSA strain 1061 were treated with plasmin. The effect of this
treatment on bacterial adhesion was studied. Adherence of the plasmin-treated strain 1061 cells
to immobilized Fn, Fgen, IgG and bovine serum albumin (BSA) was greatly increased as
compared to the untreated cells (I/Fig. 7). It was concluded that the bacterial cells might be able
to utilize the host plasminogen system to modify their adhesive properties and that this increase
in adherence might have a biological function. Later on, however, we have come to the
conclusion that the observation may not reflect specific adherence to these proteins. BSA was
used as a blocking agent in all the experiments and the increased adherence could be based on
binding to BSA or possibly some contaminating blood component in the BSA preparate, and not
specific binding to Fn, Fgen and IgG. Additionally, strain 1061 has a low expression of ClfA and
binding of the 1061 pls::TcR strain to Fgen is poor (II, III). We have not been able to show a
specific binding of strain 1061 to BSA either (unpublished) but consider that the increased
binding was due to unspecific, for example hydrophobic, interactions. Furthermore, plasmin
treatment causes cleavage of some other proteins in addition to Pls and the effect on adherence
may not be caused solely by cleavage of Pls. On the other hand, the size of Pls may have some
effect on its function in adhesion since three MRSA strains expressing Pls smaller in size than
average (two MRSA strains with a Pls band of about 175 kDa in size and one strain with Pls
bands of 190 and 97 kDa in their lysostaphin digests) gave varying (not constantly negative)
results in the clinical rapid agglutination assays (Kuusela et al., 1994). 
4.6. Effect of Pls on invasion to host cells (III)
Adenovirus type 5 DNA-transformed primary human embryonic kidney cells (293 cells) were
used to study staphylococcal invasion. Internalization of the type strain Cowan1 into these
epithelial-like cells and into human primary endothelial cells and fibroblasts had previously been
shown to be efficient and dependent on FnBP expression (Sinha et al., 1999). All of these cell
types are potentially important targets for invasion during an S. aureus infection. Invasion studies
started from an observation that in comparison to MSSA isolates eight randomly collected MRSA
isolates were only weakly invasive to 293 cells (III/Fig. 6). We examined Pls expression of these
MRSA strains, knowing that Pls expression prevents Fn adhesion and that internalization of S.
aureus into nonprofessional phagocytic cells mainly depends on Fn-mediated binding between
the staphylococcal FnBPA or FnBPB and the host cell integrin 51 or Hsp60 (Dziewanowska
et al., 1999; Fowler et al., 2000; Lammers et al., 1999; Peacock et al., 1999; Sinha et al., 1999;
Dziewanowska et al., 2000). Six of the eight weakly invasive strains were Pls+. Subsequently,
invasiveness of the ten Pls+ strains and the four Pls- MRSA strains described in chapter 4.5.1. for
their adhesion properties and adhesin expression, was studied. The Pls- strains were equally
invasive as the MSSA strain Cowan1 used as a reference strain, whereas the median invasiveness
of the Pls+ strains was only 35 % (range 22-70 %) compared to that of Cowan1. Disruption of pls
increased the invasiveness, and complementation of the mutation returned the invasiveness to the
wild type level (III/Fig. 7). Thus it seems that low invasiveness to 293 cells was caused by Pls
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expression. Two of the MRSA strains in the initial study were Pls- but still unable to invade
effectively. Because expression of adhesins was not studied in this group, the poor FnBP
expression can not be excluded as a cause for the low invasiveness. 
The role of FnBPs, the main mediators of S. aureus invasion, in virulence has been clarified in
several studies with varying results. In a rat model of endocarditis, reduced adherence by a low-
Fn-binding transposon mutant of strain 879R4S to traumatized heart valves was observed
(Kuypers and Proctor, 1989). Also, in the same infection model an apathogenic Lactococcus
lactis strain expressing FnBPA was capable of causing an infection (Que et al., 2001). On the
other hand, in another study using the same model no difference in virulence was found between
the strain 8325-4 and its isogenic FnBP-  mutant (Flock et al., 1996). In a rat model of pneumonia,
a strain 8325-4 FnBP deletion mutant showed an increased virulence (growth and acute lung
injury at 24 hours after infection) even though internalization of bacteria by alveolar epithelial
cells was FnBP dependent (McElroy et al., 2002). Some of this variation in the effect of the
FnBPs on the outcome of infection in various studies may be explained by strain-dependent
variation. Strain 8325-4 expresses FnBPs at a low level (Vaudaux et al., 2002) and shows low
in vitro invasion (Sinha et al., 1999). In strains with poor FnBP expression, invasion mediated
by the secreted adhesin Eap (Table 1) may become important (Haggar et al., 2003). Nevertheless,
based on the in vivo studies, it seems possible that a decreased ability of S. aureus cells to adhere
to Fn and to invade host cells might in some conditions even contribute to the pathogenesis of the
strain.
4.7. Role of Pls in septic arthritis (IV)
The importance of Pls as a virulence factor was investigated in a mouse model of septic arthritis
and sepsis (IV). Mouse is regarded as a good model animal for staphylococcal infections since
spontaneous staphylococcal infections also develop in mice, and murine and human immune and
inflammatory systems resemble each other. The septic arthritis model is well-established and thus
quite versatile information can be achieved by using it. MRSA strains 1061 and 1061 pls::TcR
were compared in five experiments. Additionally, the complemented strain 1061 pls::TcR (pPLS4)
was included in one of the experiments. In all experiments 15 mice per group were injected
intravenously in the tail vein. In the first experiment the mice received 4.7x107cfu of strain 1061
or 7.8x107 cfu of strain 1061 pls::TcR. During the following 14 days the wild-type-infected mice
developed a more severe arthritis and had more severe histological changes in their knee joints
than the mice infected with the mutant strain. However, mortality was high in both groups (53
% and 20 % for the groups infected with the wild type and the mutant, respectively). These results
suggested that the bacterial inoculum used in this pilot study was too high to study arthritis
optimally and too low to study mortality. In the following three experiments a lower dosage was
used to study arthritis. In one of these experiments the complemented strain was included. In the
last experiment, higher amounts of bacteria were used to optimally study sepsis-induced death.
The mice infected with strain 1061 developed a joint infection more frequently and had more
severe arthritic symptoms than the mice infected with the pls mutant strain. Complementation of
the pls mutation restored significantly, but not totally, the arthritogenic ability of the bacteria (IV/
Fig. 1). Purified Pls protein on its own was unable to cause arthritic symptoms when injected into
a knee joint of a healthy animal, suggesting that the protein must be associated to a bacterial
surface in order to cause an arthritogenic effect. Animals infected with the wild type strain had
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more severe signs of sepsis than those infected with the mutant strain. This was seen as a doubled
reduction in the weight of the animals. Complementation of the mutation restored the weight
reduction to the level of the wild type strain and even increased the effect. While the mice
challenged with the wild type and the mutant strains started to gain weight after six days from the
inoculation, the mice challenged with the complemented strain continued to lose weight (IV/Fig.
2).
The signs of sepsis were also seen as growth of bacteria in various organs and elevated cytokine
levels in serum. More bacteria could be cultured from the kidneys of mice infected with the wild
type and complemented strains, and bacteria could more often be cultured from their joints as
well, compared to the mice infected with the mutant strain (IV/Fig. 3). Serum IL-6 levels were
elevated to some extent in mice infected with the wild type or the complemented strain compared
to the mutant-infected mice. TNF- levels were measured as well but they were too low to be
reliably compared (IV/Table 1).
In the last experiment where higher bacterial doses were used, infection with the wild type strain
induced a significantly higher mortality rate than infection with the mutant strain. In five days all
the mutant-infected mice were still alive whereas 40 % of the wild-type infected mice had died.
By the end of the experiment, at day 22, 33 % of the wild-type-infected mice and 73 % of the
mutant-infected ones were alive (IV/Fig. 4). 
The complementation of pls mutation did not fully revert the properties of the strain to those of
the wild type. Arthritis induced by the complemented strain was slightly milder whereas the signs
of sepsis were slightly more serious than those induced by the wild type strain. This might be
partly due to overexpression of Pls by the complemented strain. The fate of the infection in this
model being dependent on the dosage, a higher Pls expression could, consequently, have led more
towards systemic than towards arthritic response. We were not able to answer the question of the
mechanism by which Pls expression increased the virulence. In this model, bacteria will have to
survive in blood, penetrate to the joint, colonize the joint and possibly other organs like kidneys,
and survive there. Many symptoms of septic arthritis are caused by the host response. There is,
for example, a massive infiltration of inflammatory cells to the joints during the infection
(Bremell et al., 1992). In spite of the poor ability to bind to several host proteins and the poor
ability to be internalized by kidney cells, Pls+ cells could cause a more severe infection than the
mutant cells. One mechanism that could have contributed to the increased virulence was the
increased induction of the inflammatory IL-6 cytokine by the Pls expressing strains.
Another S. aureus LPXTG protein known to cause anti-adhesiveness, Bap, shown to decrease
bacterial adherence to Fn and Fgen and reduced bacterial internalization to 293 kidney cells
(Cucarella et al., 2002) increases pathogenicity. Bap has been found only in strains that cause
mastitis in cows and in an in vivo model of ovine mastitis expression of Bap reduced colonization
of the mammary gland but on the other hand allowed the bacteria to persist longer in the tissue
(Cucarella et al., 2002; Cucarella et al., 2004). The virulence of a Pls expressing strain has been
studied in a mouse abscess model by Huesca et al. (2002) as well. They used an epidemic Pls+
MRSA strain, which was defective in expression of secreted proteins, and found that it was not
attenuated in virulence as compared to another subtype of the strain without Pls and with normal
expression of secreted proteins. An attenuated virulence would have been expected for the strain
defective in protein secretion. Since the used strains were non-isogenic, although closely related,
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the effect of Pls in virulence could not be evaluated.
4.8. pls in Staphylococcus sciuri (V)
S. aureus pls is known to be a part of an SCCmec element which contains mecA. As it has been
suggested that S. aureus mecA might originate from S. sciuri or its close evolutionary relative
(Couto et al., 1996), we searched for pls in S. sciuri strains as well. A pls homologue was
detected in 12 of 15 clinical human S. sciuri isolates by using Southern hybridization of SmaI
digested total DNA separated in PFGE (V/Fig. 1B). In 10 of these strains an S. aureus mecA
probe hybridized with the same fragment as a pls probe. The sizes of these fragments, however,
were at least 400 kb, and a close connection between the two genes could not be concluded
(V/Figs. 1B and C). Half of the strains studied were methicillin resistant and in addition to the
original S. sciuri mecA homologue which hybridized weakly with the S. aureus mecA probe, these
strains had apparently acquired a copy of mecA of S. aureus origin as hybridization with the probe
was strong (V/Fig. 1C; Couto et al., 1996). pls genes in five of these strains were examined more
carefully. S. aureus probes for all the repeat areas and the unique region of pls (II) hybridized
with DNA from these strains. Only the B repeats (R2 region) of all the strains and the unique
region of one strain were, however, amplifiable by PCR suggesting that the sequences were
similar but not identical to S. aureus pls. 
Pls was expressed by the pls+ S. sciuri strains, although at much lower levels than in S. aureus.
It could be detected in lysostaphin surface extracts using monoclonal antibodies to S. aureus Pls
(V/Fig. 2A). The S. sciuri Pls could also be purified using affinity chromatography on WGA
suggesting the presence of an associated GlcNAc containing carbohydrate part similarly to S.
aureus (V/Fig. 2B).
The presence of areas homologous to different types of S. aureus SCCmec in S. sciuri DNA was
studied using dot blot and Southern hybridizations. The probes were designed to differentiate
between the S. aureus SCCmec types in multiplex PCR (Oliveira and de Lencastre, 2002).
Additionally, probes for pls, mecA and the recombinase genes in types I, II and III SCCmec were
used. Most of the probes did not hybridize at all with DNA of the S. sciuri strains that did not
contain the S. aureus mecA gene (and, consequently, an S. aureus SCCmec). The probes
hybridizing with parts of IS431and plasmids pUB110 or pT181 (probes G and H) as well as the
probes for the recombinase genes gave a positive signal with half of the strains and the pls probe
with all the strains. It was shown that a mecA homologue was present in all the strains (V/Fig. 1)
but the hybridization conditions (68oC) in this experiment were too stringent to obtain a positive
signal (V/Table 1). Three strains (N920212, N950120 and N960546) were additionally Southern
analyzed at a lower (55oC) temperature. In addition to the positive dot blot hybridization reactions
already seen at 68oC, all the three strains hybridized with the mecA and mecI probes, strains
N920212 and N960546 also with the probe A that contained a sequence upstream of pls.
Previously, mecI has been detected only in association to the S. aureus mecA (Couto et al., 2000)
but sequences related to it seem to be present in S. sciuri as well. Some of the probes in the
Southern analysis hybridized with the same fragments with each other. To conclude, it seems that
the structure of an S. sciuri SCCmec element is at least somewhat different from the S. aureus
element, if the mecA is organized as a part of this kind of a region in S. sciuri at all.
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pls was found in S. sciuri isolates much more frequently than in MRSA isolates. This gives rise
to a hypothesis that pls, like mecA, might originate from S. sciuri. The studied strains were
different in their SmaI PFGE types. All of them, however, were clinical isolates and may not
represent the S. sciuri populations in their natural habitats. To get a wider view of the prevalence
of pls in S. sciuri, more isolates from different sources should be analyzed.
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5. CONCLUSIONS
The structural organization of Pls is typical to the LPXTG surface adhesins of S. aureus, which
would suggest an adhesive role for the molecule. In this work it was shown that Pls actually has
an anti-adhesive function in vitro as Pls expression on S. aureus surface reduces bacterial
adherence to immobilized host proteins. However, results from two other studies suggest that Pls
may have adhesive functions as well. Pls is able to adhere to cellular lipids (Huesca et al., 2002)
and promotes adherence to human desquamated nasal epithelial cells (Roche et al., 2003b).
Based on the observations in this work, we suggest that Pls prevents adhesion through steric
hindrance. Similarly to Pls, the S. aureus biofilm-associated protein Bap, found only in bovine
mastitis strains, has been shown to decrease bacterial adherence to Fn and Fgen and to reduce
bacterial internalization to 293 kidney cells (Cucarella et al., 2002). The mechanism behind the
properties of Bap has not been elucidated, but steric hindrance has been suggested for it as well.
Similarly to Pls, in addition to these anti-adhesive functions, adhesive functions have been
proposed for Bap. It increases interbacterial adhesion and bacterial binding to polystyrene
surfaces and is involved in biofilm formation (Cucarella et al., 2002). Also Pls has been reported
to promote bacterial cell-cell interactions (Huesca et al., 2002). Furthermore, Pls is homologous
to S. epidermidis accumulation associated protein Aap which has a role in biofilm formation
(Hussain et al., 1997; Schumacher-Perdreau et al., 1994). However, despite these observations,
we have not been able to show that Pls expressed by MRSA cells would promote formation of
a biofilm (K. Juuti, unpublished).
For example Fn and Fgen adhesion are certainly important for these bacteria as so many various
molecules have developed to assure these functions. Many S. aureus surface proteins also have
multiple binding specificities (see Table 1). Multifunctionality may be connected to the domain
structure with different unique and repeated regions often found in the adhesive surface proteins.
Based on this thesis and other studies Pls is multifunctional as well. The domain structure of Pls
may be responsible for its various adhesive and anti-adhesive functions, which become useful in
varying environmental conditions during an infection.
S. aureus has traditionally been regarded as an extracellular pathogen but in recent years it has
been shown to be internalized by various types of nonprofessional phagocytic host cells.
According to our results Pls expression decreased bacterial invasiveness to human kidney cells.
This correlates well with our adhesion results to immobilized Fn, as cellular invasion is known
to depend on Fn-mediated binding between the FnBPs on S. aureus surface and 51 integrin on
the host cell surface. FnBPs, like many adhesins, are controlled by the agr regulatory system and
expressed in the early exponential growth phase but not any more in the post-exponential or
stationary phase. We found that Pls is strongly expressed at all growth phases in vitro and thus
does not seem to be regulated by the agr system. Expression of the FnBPs is temporally quite
different from Pls expression in vitro, which might have an effect on the interplay of the two
proteins. How Pls is expressed in vivo is not known and whether host cell invasion actually is a
pathogenic mechanism for S. aureus is still controversial. There are contradictory results on the
importance of FnBPs in virulence as well (Table 1). In a rat model of pneumonia, a strain 8325-4
FnBP deletion mutant showed an even increased virulence (McElroy et al., 2002) suggesting that
in some conditions a decreased adhesion and cellular invasion might even contribute to S. aureus
pathogenesis.
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S. aureus is a versatile pathogen causing a wide variety of infections at different body sites.
Conditions in vivo, inside the host, are complicated and many bacterial and host molecules as well
as the host defence system are involved in bacterial infections. Even though Pls prevented
adhesion to immobilized host proteins, we found that the binding of soluble proteins, especially
of IgG, was not affected. These in vitro observations might reflect the various conditions that the
MRSA cells meet in the host body. Fn is found both insoluble in the ECM and soluble in plasma,
laminin is a major component of basement membranes. Fgen is abundant in plasma, but
frequently becomes immobilized as fibrin in blood clots. IgG is mainly a soluble plasma
molecule. Also the agr dependent global regulation of virulence factors affects the behaviour of
bacterial cells in various conditions. It is thought to lead to an increased adherence in vivo at low
cell concentrations favouring colonization. When the cell density increases, secreted exoproteins
are induced, leading to shut-off of adhesin synthesis and favouring spread to other tissues
(reviewed by Novick, 2003). 
Based on the anti-adhesive and anti-invasive functions of Pls we expected that the Pls-expressing
MRSA strains might be less pathogenic than the non-Pls strains. Surprisingly, Pls was shown to
increase virulence in our mouse model of septic arthritis. The net result of various in vitro anti-
adhesive and adhesive properties thus seemed to be an increased in vivo pathogenicity caused by
Pls for sepsis, for induction of arthritis and for sepsis-induced death. Possible cell-cell interactions
induced by Pls, leading to clumping and biofilm formation at some point of an infection might
be one mechanism increasing virulence. Binding of Pls to lipids could also increase binding to
cellular surfaces. At some stages of an infection it may be useful for the bacterial cell to be able
to adhere or get internalized by a eukaryotic cell, whereas at another time it may be the opposite.
From this point of view, the ability of Pls to modulate host protein binding may be significant
also in vivo.
It has been suggested that mecA originates from Staphylococcus sciuri or its close evolutionary
relative. We showed that pls was common in clinical isolates of S. sciuri and hypothesize that S.
aureus might have acquired it from S. sciuri like suggested for mecA. pls was part of the SCCmec
region of already the first MRSA strain, NCTC10442, isolated in 1961 (Ito et al., 2001). It
continues to be found in current MRSA isolates, even epidemic ones, like the Canadian epidemic
MRSA, CMRSA-1 subtype B, which was reported to account for 35 % of all hospital MRSA
isolates in Canada in the year 2000 (Papakyriacou et al., 2000). Here in Finland the so called
Töölö MRSA, currently epidemic in hospitals of Helsinki and some other areas of this country,
is Pls-positive. It seems that bacterial genomes are under a constant change. Genes or even larger
elements, like the SCC elements, are changed between strains and even between species. This
leads to new combinations potentially useful in a changing environment like after introduction
of new antibiotics. Sometimes, as suggested for the mecA product, PBP2a, and possibly for Pls,
the functions of the molecules in a changed genetic background may differ from the original. 
The starting point of this study was a problem in S. aureus identification tests. Pls was found in
MRSA strains that did not agglutinate in rapid tests based on interactions between IgG and Fgen
on the surface of test particles and protein A and ClfA (and other Fgen-binding proteins) on the
staphylococcal surface (Kuusela et al., 1994). The non-agglutinating phenotype can now be
explained by Pls preventing the interactions between the MRSA surface molecules and the
molecules immobilized on the particle surface. More effective "second generation" agglutination
tests have later been introduced, which utilize e.g. specific antibodies towards the most common
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S. aureus capsule types in addition to IgG and Fgen, and which consequently detect also most
MRSA strains expressing Pls. Even better agglutination tests could be developed by using
antibodies to Pls as additional test components. Pls could also have other use in diagnostics. We
have found that Pls, due to its carbohydrate portion, cross reacts with teichoic acid antibodies in
sera of patients with S. aureus infections (K. Juuti, P. Tissari & P. Kuusela, unpublished). This
raises a possibility that Pls could be used as a tool to detect deep S. aureus infections. Yet another
potential use for Pls is in epidemiological studies, where variation in the sizes of the pls repeat
regions could be used as an additional method to quickly determine whether two strains are
identical or not. Also, if Pls and its homologues actually mediate nasal colonization, vaccination
by Pls would open a great possibility to fight against MRSA carriage. 
In addition to the diagnostic aspects, the carbohydrate portion of Pls will deserve more attention
in future studies. Its composition and localization in Pls molecule, as well as its effect on various
functions of Pls, are worth studying. A more careful analysis of Pls functions, especially the role
of various domains in the adhesive and anti-adhesive properties, is of interest. Also, a study on
the prevalence of pls in non-human S. sciuri strains will be needed.
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